4//SEC Filing
Plant Michael P. 4
Accession 0001104659-25-119293
CIK 0001958140other
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 4:07 PM ET
Size
12.5 KB
Accession
0001104659-25-119293
Insider Transaction Report
Form 4
Plant Michael P.
EVP, Development
Transactions
- Exercise/Conversion
Series C Common Stock
2025-12-04+20,000→ 248,218 total - Sale
Series C Common Stock
2025-12-05$38.65/sh−8,893$343,714→ 239,325 total - Exercise/Conversion
Restricted Stock Units - BATRK
2025-12-04−20,000→ 0 totalFrom: 2025-12-04Exp: 2025-12-04→ Series C Common Stock (20,000 underlying) - Award
Restricted Stock Units - BATRK
2025-12-04+20,731→ 20,731 totalFrom: 2026-12-04Exp: 2026-12-04→ Series C Common Stock (20,731 underlying)
Holdings
- 55,503(indirect: By Trust)
Series C Common Stock
Footnotes (5)
- [F1]Each restricted stock unit converted into one share of Series C Common Stock.
- [F2]Reflects 22,625 shares of Series C Common Stock previously held indirectly by the reporting person through his Grantor Retained Annuity Trust ("GRAT") and subsequently returned to the reporting person in satisfaction of the GRAT's annuity obligation.
- [F3]The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of the restricted stock units.
- [F4]Reflects the weighted average sale price. The range of prices for such transaction is $38.43 to $38.81. Upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F5]Each restricted stock unit represents a contingent right to receive one share of Series C Common Stock.
Documents
Issuer
Atlanta Braves Holdings, Inc.
CIK 0001958140
Entity typeother
Related Parties
1- filerCIK 0002036190
Filing Metadata
- Form type
- 4
- Filed
- Dec 7, 7:00 PM ET
- Accepted
- Dec 8, 4:07 PM ET
- Size
- 12.5 KB